Cryogenic OGS Limited (BOM:544440)
India
· Delayed Price · Currency is INR 175.45
+10.30 (6.24%)
At close: Mar 9, 2026
Cryogenic OGS Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
| Revenue | 405.55 | 329.05 | 242.54 | 220.22 | 233.3 | 228.1 |
| Revenue Growth (YoY) | - | 35.67% | 10.14% | -5.61% | 2.28% | - |
| Cost of Revenue | 226.14 | 189.37 | 135.61 | 121.7 | 151.26 | 143.02 |
| Gross Profit | 179.42 | 139.68 | 106.93 | 98.51 | 82.05 | 85.07 |
| Selling, General & Admin | 22.77 | 20.1 | 16.87 | 14.67 | 17.41 | 17.17 |
| Other Operating Expenses | 56.29 | 39.97 | 22.48 | 27.23 | 21.17 | 29.92 |
| Operating Expenses | 84.29 | 65.27 | 45 | 48.67 | 43.44 | 51.68 |
| Operating Income | 95.13 | 74.41 | 61.93 | 49.84 | 38.61 | 33.4 |
| Interest Expense | -0.18 | -0.24 | -0.86 | -1.08 | -0.75 | -0.64 |
| Interest & Investment Income | 8.47 | 8.47 | 7.61 | 4.68 | 5.41 | 3.82 |
| Currency Exchange Gain (Loss) | 0.02 | 0.02 | 0.02 | -0.13 | 0.01 | 1.28 |
| Other Non Operating Income (Expenses) | 1.81 | -0.36 | -0.34 | -0.73 | -0.29 | -0.64 |
| EBT Excluding Unusual Items | 105.25 | 82.3 | 68.37 | 52.59 | 42.99 | 37.22 |
| Gain (Loss) on Sale of Investments | - | - | 1.62 | 2.19 | 1.28 | 0.77 |
| Gain (Loss) on Sale of Assets | 12.66 | 0.26 | 1.22 | - | - | 0.26 |
| Pretax Income | 118.02 | 82.68 | 71.2 | 54.78 | 44.27 | 38.25 |
| Income Tax Expense | 29.46 | 21.45 | 17.75 | 14.01 | 11.45 | 9.63 |
| Net Income | 88.56 | 61.23 | 53.45 | 40.77 | 32.81 | 28.62 |
| Net Income to Common | 88.56 | 61.23 | 53.45 | 40.77 | 32.81 | 28.62 |
| Net Income Growth | - | 14.55% | 31.12% | 24.23% | 14.64% | - |
| Shares Outstanding (Basic) | 11 | 11 | 11 | 11 | 11 | 11 |
| Shares Outstanding (Diluted) | 11 | 11 | 11 | 11 | 11 | 11 |
| EPS (Basic) | 7.80 | 5.83 | 5.09 | 3.88 | 3.13 | 2.73 |
| EPS (Diluted) | 7.80 | 5.83 | 5.09 | 3.88 | 3.13 | 2.73 |
| EPS Growth | - | 14.54% | 31.19% | 24.15% | 14.64% | - |
| Free Cash Flow | 12.3 | 16.62 | 15.26 | 14.43 | 6.46 | 23.02 |
| Free Cash Flow Per Share | 1.08 | 1.58 | 1.45 | 1.38 | 0.62 | 2.19 |
| Gross Margin | 44.24% | 42.45% | 44.09% | 44.73% | 35.17% | 37.30% |
| Operating Margin | 23.46% | 22.61% | 25.54% | 22.63% | 16.55% | 14.64% |
| Profit Margin | 21.84% | 18.61% | 22.04% | 18.51% | 14.06% | 12.55% |
| Free Cash Flow Margin | 3.03% | 5.05% | 6.29% | 6.55% | 2.77% | 10.09% |
| EBITDA | 100.36 | 79.61 | 67.58 | 56.58 | 43.45 | 37.98 |
| EBITDA Margin | 24.75% | 24.19% | 27.86% | 25.69% | 18.63% | 16.65% |
| D&A For EBITDA | 5.23 | 5.2 | 5.64 | 6.73 | 4.85 | 4.58 |
| EBIT | 95.13 | 74.41 | 61.93 | 49.84 | 38.61 | 33.4 |
| EBIT Margin | 23.46% | 22.61% | 25.54% | 22.63% | 16.55% | 14.64% |
| Effective Tax Rate | 24.96% | 25.95% | 24.93% | 25.58% | 25.87% | 25.16% |
| Revenue as Reported | 416.59 | 337.91 | 256.74 | 227.09 | 240 | 234.3 |
| Advertising Expenses | - | - | - | - | 0.01 | - |
Source: S&P Capital IQ. Standard template. Financial Sources.